RW
TGTX icon

REDW Wealth’s TG Therapeutics TGTX Stock Holding History

REDW Wealth’s Portfolio TGTX Stock Details TGTX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q4 		– Sell
-10,000
Closed -$361K – 113
2025
Q3 		$361K Hold
10,000
– – 0.14% 74
2025
Q2 		$360K Hold
10,000
– – 0.14% 71
2025
Q1 		$394K Hold
10,000
– – 0.15% 66
2024
Q4 		$301K Hold
10,000
– – 0.1% 80
2024
Q3 		$234K Hold
10,000
– – 0.06% 150
2024
Q2 		$178K Hold
10,000
– – 0.05% 156
2024
Q1 		$152K Hold
10,000
– – 0.04% 160
2023
Q4 		$171K Hold
10,000
– – 0.05% 148
2023
Q3 		$83.6K Buy
+10,000
New +$139K 0.03% 141

Other funds holding TGTX

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
ClearBridge Investments
ClearBridge Investments New York $121B AUM 27.52% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
SCM
Soleus Capital Management Greenwich, Connecticut $2.9B AUM 169.69% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return
CAM
Congress Asset Management Boston, Massachusetts $16.3B AUM 42.69% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return
HRCM
Hood River Capital Management Palm Beach Gardens, Florida $13.8B AUM 163.97% 1-Year Est. Return

REDW Wealth's TGTX Position: Q4 2025 in Review

REDW Wealth sold out of TG Therapeutics (TGTX) in Q4 2025, closing a stake of 10,000 shares — an estimated $361K sold.

REDW Wealth first reported a position in TGTX in Q3 2023 and held it in 9 quarters. The position peaked at $394K in Q1 2025. 352 funds tracked by Wall St. Rank hold TGTX as of Q4 2025.

  • REDW Wealth reported no remaining TG Therapeutics position as of Q4 2025 after selling out during the quarter.
  • REDW Wealth sold 10,000 TG Therapeutics shares in Q4 2025, an estimated $361K.
  • REDW Wealth first reported a position in TG Therapeutics in Q3 2023 and held it in 9 quarters.
  • REDW Wealth's TG Therapeutics position peaked at $394K in Q1 2025.
  • 352 funds tracked by Wall St. Rank held TG Therapeutics as of Q4 2025.

Based on REDW Wealth's 13F filing for Q4 2025, filed 28 Jan 2026.